Patents by Inventor Ronald S. Newbower

Ronald S. Newbower has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8547220
    Abstract: A system is provided for establishing a compliance zone and monitoring interactions therewith. The system includes a compliance zone designator and a wearable device. The compliance zone designator transmits an ultrasound signal to establish the compliance zone. The ultrasound signal may be encoded with information on the compliance zone. The compliance zone designator is configured for placement at a location in which the compliance zone is desired. The wearable device is separate from the compliance zone designator. The wearable device includes a compliance zone recognition component configured to recognize the compliance zone and identify one or more pre-defined interaction criteria for the compliance zone. When the wearable device is within the compliance zone, the compliance zone recognition component recognizes the compliance zone and identifies the interaction criteria of the compliance zone.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: October 1, 2013
    Assignee: The General Hospital Corporation
    Inventors: Michael Dempsey, Ronald S. Newbower
  • Patent number: 8212653
    Abstract: A system is provided for establishing a protected zone and monitoring interactions therewith. The system includes a protected zone designator and a wearable device. The protected zone designator establishes the protected zone. The protected zone designator is configured for placement at a location in which the protected zone is desired. The wearable device is separate and distal from the protected zone designator. The wearable device includes a protected zone recognition component configured to recognize the protected zone and identify pre-defined interaction criteria for the protected zone. Upon the wearable device entering the protected zone, the protected zone recognition component recognizes the protected zone and identifies the interaction criteria of the protected zone. Based on the interaction criteria the wearable device determines and records compliance with the interaction criteria.
    Type: Grant
    Filed: March 20, 2008
    Date of Patent: July 3, 2012
    Assignee: The General Hospital Corp.
    Inventors: Arthur L. Goldstein, Michael K. Dempsey, Ronald S. Newbower
  • Patent number: 8164439
    Abstract: A system is provided for establishing a compliance zone and monitoring interactions therewith. The system includes a compliance zone designator and a wearable device. The compliance zone designator transmits an ultrasound signal to establish the compliance zone. The ultrasound signal may be encoded with information on the compliance zone. The compliance zone designator is configured for placement at a location in which the compliance zone is desired. The wearable device is separate from the compliance zone designator. The wearable device includes a compliance zone recognition component configured to recognize the compliance zone and identify one or more pre-defined interaction criteria for the compliance zone. When the wearable device is within the compliance zone, the compliance zone recognition component recognizes the compliance zone and identifies the interaction criteria of the compliance zone.
    Type: Grant
    Filed: June 18, 2009
    Date of Patent: April 24, 2012
    Assignee: The General Hospital Corp.
    Inventors: Michael K. Dempsey, Ronald S. Newbower
  • Publication number: 20100321180
    Abstract: A system is provided for establishing a compliance zone and monitoring interactions therewith. The system includes a compliance zone designator and a wearable device. The compliance zone designator transmits an ultrasound signal to establish the compliance zone. The ultrasound signal may be encoded with information on the compliance zone. The compliance zone designator is configured for placement at a location in which the compliance zone is desired. The wearable device is separate from the compliance zone designator. The wearable device includes a compliance zone recognition component configured to recognize the compliance zone and identify one or more pre-defined interaction criteria for the compliance zone. When the wearable device is within the compliance zone, the compliance zone recognition component recognizes the compliance zone and identifies the interaction criteria of the compliance zone.
    Type: Application
    Filed: June 18, 2009
    Publication date: December 23, 2010
    Applicant: THE GENERAL HOSPITAL CORP.
    Inventors: Michael K. DEMPSEY, Ronald S. Newbower
  • Patent number: 4817624
    Abstract: A composite catheter for in vivo fluid injection is provided in which a thin tube is located within the lumen of a conventional catheter. The thin tube has a small diameter inner passage for the in vivo injection of a fluid. The passage is accessible for fluid application at the exterior catheter end and passes through the catheter wall at a port in the lumen to the catheter exterior for fluid injection into the blood stream or elsewhere. A sensing device, such as a thermistor, is mounted on the catheter downstream of the port to measure changes in the properties of the fluid resulting from fluid injection for thermodilution applications. The space within the lumen insulates the fluid from the catheter environment and the small bore inner passage reduces resident fluid permitting small fluid injections that accommodate frequent injection measurements.
    Type: Grant
    Filed: December 20, 1985
    Date of Patent: April 4, 1989
    Assignee: The General Hospital Corporation
    Inventor: Ronald S. Newbower
  • Patent number: 4676252
    Abstract: Patient monitoring method and apparatus for measurement of in vivo extra vascular lung water (pulmonary edema) and pulmonary circulatory system thermal bypass utilizing double indicator dilution with temperature and electrical conductivity modifiers. A thermal modifier is utilized for a primary indicator dilution measurement with electrical conductivity provided as a reference indicator which in turn is corrected for temperature effects produced by the thermal moderator as well as effects of plasma characteristics. Thermal and conductivity sensors are both placed upstream and downstream of the lungs in the pulmonary artery and thesystemic arterial system, and a thermal and conductivity moderator is injected at a site upstream from both. Temperature and conductivity are detected at both sites and the conductivity signal is converted to a volume dilution valve.
    Type: Grant
    Filed: October 9, 1985
    Date of Patent: June 30, 1987
    Assignee: Massachusetts General Hospital
    Inventors: Edwin D. Trautman, Ronald S. Newbower
  • Patent number: 4537128
    Abstract: A system designed to enable persons incapable of manipulating a writing implement to sign papers and/or documents comprising a holder for the document to be signed, a holder for a transfer sheet for holding the transfer sheet adjacent that portion of the document to be signed and an implement defining the signature to be applied to the document for pressing the transfer sheet into transferring engagement with the document.
    Type: Grant
    Filed: October 20, 1983
    Date of Patent: August 27, 1985
    Assignee: Massachusetts General Hospital
    Inventors: Robert H. Burroughs, John D. Wright, Jeffrey A. Secunda, Ronald S. Newbower
  • Patent number: 4380237
    Abstract: An improved catheter probe includes a conductivity sensor comprising four electrodes configured and spaced to be electrically coupled together by vascular fluids. A current source is provided for driving current through the vascular fluid between one pair of electrodes, and voltage sensing means is provided for measuring the voltage between the other pair of electrodes. In the preferred embodiment, the electrodes are closely spaced, substantially parallel electrodes oriented along the longitudinal direction of the catheter and transversely spaced apart by a distance which is small compared to the diameter of the catheter. The longitudinal length of the electrodes is chosen to be large as compared to the transverse spacing. The preferred current source is an isolated AC source, and the preferred voltage detection means is a phase sensitive voltage detector selectively responsive to the frequency and phase of the current source.
    Type: Grant
    Filed: August 17, 1981
    Date of Patent: April 19, 1983
    Assignee: Massachusetts General Hospital
    Inventor: Ronald S. Newbower
  • Patent number: 4236527
    Abstract: Method and apparatus for measuring cardiac output in which a traceable signal in the form of thermal energy or an injectate is applied to the blood flow through the heart having a plurality of frequency components with the traceable signal detected at a heart output vessel and analyzed at the plural frequency components to provide cardiac output rate and ejection fraction information. The traceable signal is preferably heat energy applied as a very low frequency modulation of a high frequency signal at a fundamental and further harmonic or as a square wave in which multiple harmonics are present. At least two frequency components of the square wave are then separately analyzed. A multiple frequency system in addition to permitting analysis of previously undetectable heart output characteristics additionally permits determination of whether the source of the traceable signal is properly located within the heart such as in the ventricle.
    Type: Grant
    Filed: October 20, 1978
    Date of Patent: December 2, 1980
    Assignee: Massachusetts General Hospital
    Inventors: Ronald S. Newbower, James H. Philip